DC Advisory acts as exclusive financial advisor to SPIE on its acquisition of OTTO LSE from Equistone
Background
- Otto Life Science Engineering GmbH (OTTO LSE) is a specialized Engineering, Procurement, and Construction (EPC) provider for pharmaceutical and biotech production facilities and laboratories. The company covers the entire value chain; from planning, design, and delivery to re-qualifying - providing turnkey solutions in process design, pure media, clean room and building technology
- Funds advised by Equistone Partners Europe (Equistone) acquired a majority stake in OTTO LSE in 2017
- OTTO LSE, founded in 2017 and headquartered in Germany, operates six offices across the country. In 2023, the company generated close to €75mn in revenue with approximately 140 employees
- Based in France, SPIE SA (SPIE), listed on NYSE Euronext Paris, is an independent European leader in multi-technical services in the areas of energy and communications
Process
- DC Advisory was exclusively engaged by SPIE to provide buy-side advice for the acquisition of OTTO LSE
- DC Advisory leveraged its engineering and building technology sector expertise to support SPIE with valuation, process-related and strategic advice throughout the process
Outcome
- In July 2024, SPIE signed an agreement to acquire 87% in OTTO LSE
- The remaining 13% shareholding will be retained by the current management team who will further develop the company together with SPIE
- This acquisition will enable SPIE to reinforce its presence in the attractive and dynamic pharmaceutical and biotech sectors
- This transaction is subject to customary closing conditions
- This transaction further demonstrates DC Advisory’s strong track record of providing comprehensive and tailored buy-side advice to companies in the engineering and building technology sectors
“The acquisition of OTTO LSE enables SPIE to accelerate on the dynamic EPC market for pharmaceutical and biotech customers with a reputable player benefitting from a very high added value positioning. The unique know-how of the company, combined with the very high barriers to entry largely contribute to the high recurring level of profitability. This operation will strengthen SPIE’s position, expertise and client portfolio in Industry Services in Germany. We are pleased to welcome the management of OTTO LSE and its team to SPIE.”
“With OTTO LSE, we continue the development of our expertise in Germany in very attractive markets and we are delighted to welcome the management and its highly skilled team. This combination will allow to further develop the business. With its experienced management team and entrepreneurial approach, SPIE and OTTO LSE will be value creative for the future.”
“We are proud and privileged to assist SPIE on the acquisition of OTTO LSE. OTTO LSE will act as an enabler to boost SPIE’s strategy to grow the German pharmaceutical and biotech market. We are excited about the next level of growth and wish them all the best in their future endeavors.”
“We are delighted to have supported SPIE on their acquisition of OTTO LSE. We believe that this combination will strengthen and further expand OTTO LSE’s market position.”
- Business & Tech-Enabled Services
Disclaimer
For more information, please see our transaction disclaimer
For important information regarding testimonials, please see our disclaimer.